Testing effectiveness (Phase 2)Looking for participantsNCT06807593
What this trial is testing
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
Who this might be right for
Cancer
M.D. Anderson Cancer Center 10